Do predictors of incomplete Kawasaki disease exist for infants? (Q48366077)

11 February 2018

title

Do predictors of incomplete Kawasaki disease exist for infants? (English)

1 reference

11 February 2018

1 reference

Sol Ji No

1

1 reference

11 February 2018

Dong Ouk Kim

series ordinal

2

1 reference

11 February 2018

Kyong Min Choi

series ordinal

3

1 reference

11 February 2018

Lucy Youngmin Eun

series ordinal

4

1 reference

11 February 2018

publication date

22 September 2012

1 reference

11 February 2018

published in

Pediatric Cardiology

1 reference

11 February 2018

volume

34

1 reference

11 February 2018

issue

2

1 reference

11 February 2018

page(s)

286-290

1 reference

11 February 2018

https://scigraph.springernature.com/pub.10.1007/s00246-012-0440-3

exact match

0 references

cites work

Clinical spectrum of Kawasaki disease in infants younger than 6 months of age.

1 reference

https://api.crossref.org/works/10.1007%2FS00246-012-0440-3

Characteristics of Kawasaki disease in infants younger than six months of age

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00246-012-0440-3

Natriuretic peptide as an adjunctive diagnostic test in the acute phase of Kawasaki disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00246-012-0440-3

Kawasaki disease in infants less than one year of age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00246-012-0440-3

Coronary artery involvement in children with Kawasaki disease: risk factors from analysis of serial normalized measurements

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00246-012-0440-3

Extreme thrombocytosis predicts Kawasaki disease in infants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00246-012-0440-3

Regression of coronary aneurysms in patients with Kawasaki syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00246-012-0440-3

Abnormal tissue doppler images are associated with elevated plasma brain natriuretic peptide and increased oxidative stress in acute Kawasaki disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00246-012-0440-3

Performance of 2004 American Heart Association recommendations for treatment of Kawasaki disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00246-012-0440-3

Kawasaki syndrome in infants in the first 6 months of life

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00246-012-0440-3

Left ventricular contractility and function in Kawasaki syndrome. Effect of intravenous gamma-globulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00246-012-0440-3

Diastolic function in children with Kawasaki disease

21 January 2018

1 reference

12 December 2020

Clinical characteristics of Kawasaki disease according to age at diagnosis.

1 reference

12 December 2020

[Clinical analysis of Kawasaki disease in infants below 6 months of age]

1 reference

12 December 2020

Effects of immunoglobulin and gamma-interferon on the production of tumour necrosis factor-alpha and interleukin-1 beta by peripheral blood monocytes in the acute phase of Kawasaki disease

1 reference

12 December 2020

Risk of coronary abnormalities due to Kawasaki disease in urban area with small Asian population.

1 reference

12 December 2020

1 reference

12 December 2020

1 reference

12 December 2020

1 reference

12 December 2020

Plasma brain natriuretic peptide concentrations in patients with Kawasaki disease

1 reference

12 December 2020

10.1007/S00246-012-0440-3

Identifiers

DOI

1 reference

11 February 2018

1 reference

11 February 2018